Cargando…

A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry

Multiplex immunophenotyping technologies are indispensable for a deeper understanding of biological systems. Until recently, high-dimensional cellular analyses implied the loss of tissue context as they were mostly performed in single-cell suspensions. The advent of imaging mass cytometry introduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Ijsselsteijn, Marieke E., van der Breggen, Ruud, Farina Sarasqueta, Arantza, Koning, Frits, de Miranda, Noel F. C. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830340/
https://www.ncbi.nlm.nih.gov/pubmed/31736961
http://dx.doi.org/10.3389/fimmu.2019.02534
_version_ 1783465761425063936
author Ijsselsteijn, Marieke E.
van der Breggen, Ruud
Farina Sarasqueta, Arantza
Koning, Frits
de Miranda, Noel F. C. C.
author_facet Ijsselsteijn, Marieke E.
van der Breggen, Ruud
Farina Sarasqueta, Arantza
Koning, Frits
de Miranda, Noel F. C. C.
author_sort Ijsselsteijn, Marieke E.
collection PubMed
description Multiplex immunophenotyping technologies are indispensable for a deeper understanding of biological systems. Until recently, high-dimensional cellular analyses implied the loss of tissue context as they were mostly performed in single-cell suspensions. The advent of imaging mass cytometry introduced the possibility to simultaneously detect a multitude of cellular markers in tissue sections. This technique can be applied to various tissue sources including snap-frozen and formalin-fixed, paraffin-embedded (FFPE) tissues. However, a number of methodological challenges must be overcome when developing large antibody panels in order to preserve signal intensity and specificity of antigen detection. We report the development of a 40-marker panel for imaging mass cytometry on FFPE tissues with a particular focus on the study of cancer immune microenvironments. It comprises a variety of immune cell markers including lineage and activation markers as well as surrogates of cancer cell states and tissue-specific markers (e.g., stroma, epithelium, vessels) for cellular contextualization within the tissue. Importantly, we developed an optimized workflow for maximum antibody performance by separating antibodies into two distinct incubation steps, at different temperatures and incubation times, shown to significantly improve immunodetection. Furthermore, we provide insight into the antibody validation process and discuss why some antibodies and/or cellular markers are not compatible with the technique. This work is aimed at supporting the implementation of imaging mass cytometry in other laboratories by describing methodological procedures in detail. Furthermore, the panel described here is an excellent immune monitoring tool that can be readily applied in the context of cancer research.
format Online
Article
Text
id pubmed-6830340
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68303402019-11-15 A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry Ijsselsteijn, Marieke E. van der Breggen, Ruud Farina Sarasqueta, Arantza Koning, Frits de Miranda, Noel F. C. C. Front Immunol Immunology Multiplex immunophenotyping technologies are indispensable for a deeper understanding of biological systems. Until recently, high-dimensional cellular analyses implied the loss of tissue context as they were mostly performed in single-cell suspensions. The advent of imaging mass cytometry introduced the possibility to simultaneously detect a multitude of cellular markers in tissue sections. This technique can be applied to various tissue sources including snap-frozen and formalin-fixed, paraffin-embedded (FFPE) tissues. However, a number of methodological challenges must be overcome when developing large antibody panels in order to preserve signal intensity and specificity of antigen detection. We report the development of a 40-marker panel for imaging mass cytometry on FFPE tissues with a particular focus on the study of cancer immune microenvironments. It comprises a variety of immune cell markers including lineage and activation markers as well as surrogates of cancer cell states and tissue-specific markers (e.g., stroma, epithelium, vessels) for cellular contextualization within the tissue. Importantly, we developed an optimized workflow for maximum antibody performance by separating antibodies into two distinct incubation steps, at different temperatures and incubation times, shown to significantly improve immunodetection. Furthermore, we provide insight into the antibody validation process and discuss why some antibodies and/or cellular markers are not compatible with the technique. This work is aimed at supporting the implementation of imaging mass cytometry in other laboratories by describing methodological procedures in detail. Furthermore, the panel described here is an excellent immune monitoring tool that can be readily applied in the context of cancer research. Frontiers Media S.A. 2019-10-29 /pmc/articles/PMC6830340/ /pubmed/31736961 http://dx.doi.org/10.3389/fimmu.2019.02534 Text en Copyright © 2019 Ijsselsteijn, van der Breggen, Farina Sarasqueta, Koning and de Miranda. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Ijsselsteijn, Marieke E.
van der Breggen, Ruud
Farina Sarasqueta, Arantza
Koning, Frits
de Miranda, Noel F. C. C.
A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry
title A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry
title_full A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry
title_fullStr A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry
title_full_unstemmed A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry
title_short A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry
title_sort 40-marker panel for high dimensional characterization of cancer immune microenvironments by imaging mass cytometry
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830340/
https://www.ncbi.nlm.nih.gov/pubmed/31736961
http://dx.doi.org/10.3389/fimmu.2019.02534
work_keys_str_mv AT ijsselsteijnmariekee a40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry
AT vanderbreggenruud a40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry
AT farinasarasquetaarantza a40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry
AT koningfrits a40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry
AT demirandanoelfcc a40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry
AT ijsselsteijnmariekee 40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry
AT vanderbreggenruud 40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry
AT farinasarasquetaarantza 40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry
AT koningfrits 40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry
AT demirandanoelfcc 40markerpanelforhighdimensionalcharacterizationofcancerimmunemicroenvironmentsbyimagingmasscytometry